The Committee for Medicinal Products for Human Use (CHMP) is the European Medicines Agency's (EMA) committee responsible for human medicines. It plays a vital role in the …

More information can be found under 'Committee for Medicinal Products for Human Use (CHMP)'.

The European Medicines Agency (EMA) publishes details of the members and alternates of its Committee for Medicinal Products for Human Use (CHMP).

Jun 27, 2024 · The CHMP adopted a positive opinion for Eurneffy (epinephrine), the first emergency treatment against allergic reactions that is administered as a nasal spray, not as …

Each month, the European Medicines Agency's (EMA) publishes an updated list of medicines for human use currently under evaluation by EMA’s Committee for Medicinal Products for Human …

Jan 30, 2025 · The CHMP recommended granting a marketing authorisation for Capvaxive (pneumococcal polysaccharide conjugate vaccine (21-valent)), a vaccine intended for the …

Sep 19, 2024 · The CHMP gave positive opinions to update the composition of the mRNA vaccine Spikevax 1, to target the SARS-CoV-2 JN.1 variant of the virus that causes COVID-19, and …

The CHMP rapporteur’s and co-rapporteur’s teams assess the evidence provided on the medicine and independently prepare their assessment reports, where they highlight any issues or …

Dec 12, 2024 · The CHMP recommended granting a marketing authorisation for Andembry* (garadacimab), for the prevention of recurrent attacks of hereditary angioedema, a rare, …

Jul 25, 2024 · EMA’s human medicines committee (CHMP) recommended 14 medicines for approval at its July 2024 meeting. The CHMP recommended granting a marketing …